bromocriptine has been researched along with butaclamol in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (56.25) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| George, SR; Guan, HC; Laurier, LG; Ng, G; Niznik, HB; O'Dowd, BF; Seeman, P; Sunahara, RK; Torchia, J; Van Tol, HH | 1 |
| Emms, F; Freedman, SB; Knowles, MR; Marwood, R; McAllister, G; Patel, S; Seabrook, GR | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Goldstein, M; Hata, F; Lew, JY; Ohashi, T | 1 |
| Dannies, PS; West, B | 1 |
| Cestari, R; Lojacono, L; Memo, M; Missale, C; Missale, G; Sigala, S; Spano, P | 1 |
| Adams, EF; Fahlbusch, R; Nomikos, P; Reif, M; Schrell, UM | 1 |
| Barden, N; L'Héreault, S | 1 |
| Gessa, GL; Olianas, MC; Onali, P | 1 |
| Dieguez, C; Hall, R; Lewis, BM; Lewis, M; Scanlon, MF | 1 |
| Liberini, P; Memo, M; Missale, C; Spano, P | 1 |
| Anderson, SM; Schaeffer, JM | 1 |
| Denef, C; Dewals, R; Manet, D | 1 |
| Cronin, MJ; Faure, N; Martial, JA; Weiner, RI | 1 |
| Levitin, HP; Mezzadri-Levitin, MR | 1 |
| Fu, D; Javitch, JA; Lin, H; Strange, PG; Wilson, J | 1 |
16 other study(ies) available for bromocriptine and butaclamol
| Article | Year |
|---|---|
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain; Cell Line; Cell Membrane; Cloning, Molecular; Dopamine; Humans; Kinetics; Molecular Sequence Data; Molecular Weight; Oligonucleotide Probes; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D5; RNA, Messenger; Sequence Homology, Nucleic Acid; Transfection | 1991 |
Expression and pharmacological characterization of the human D3 dopamine receptor.
Topics: Animals; Binding, Competitive; Cells, Cultured; CHO Cells; Cricetinae; Dopamine; Dopamine Antagonists; GTP-Binding Proteins; Guanine Nucleotides; Humans; Potassium Channels; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Recombinant Proteins; Second Messenger Systems; Sulpiride | 1994 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
The interactions of bromocriptine and lergotrile with dopamine and alpha-adrenergic receptors.
Topics: Acetonitriles; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Apomorphine; Binding Sites; Brain; Bromocriptine; Butaclamol; Cattle; Cerebral Cortex; Corpus Striatum; Dihydroergotoxine; Dopamine; Ergolines; Haloperidol; In Vitro Techniques; Osmolar Concentration; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Synaptosomes; Tyrosine 3-Monooxygenase | 1977 |
Antipsychotic drugs inhibit prolactin release from rat anterior pituitary cells in culture by a mechanism not involving the dopamine receptor.
Topics: Animals; Bromocriptine; Butaclamol; Cells, Cultured; Dibenzocycloheptenes; Growth Hormone; Kinetics; Male; Pituitary Gland, Anterior; Prolactin; Rats; Receptors, Dopamine; Tartrates | 1979 |
Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Adult; Benzazepines; Bromocriptine; Butaclamol; Dopamine Agents; Dose-Response Relationship, Drug; Esophagus; Fenoldopam; Humans; Male; Middle Aged; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 1990 |
Growth of cultured human cerebral meningiomas is inhibited by dopaminergic agents. Presence of high affinity dopamine-D1 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Apomorphine; Benzazepines; Binding, Competitive; Bromocriptine; Butaclamol; Cell Division; Dopamine; Dopamine Agents; Humans; Meningioma; Receptors, Dopamine; Receptors, Dopamine D1; Tumor Cells, Cultured | 1990 |
Monoaminergic regulation of proopiomelanocortin messenger RNA concentrations in primary cell cultures of rat hypothalamus.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Bromocriptine; Butaclamol; Cells, Cultured; Dexamethasone; Dopamine; Embryo, Mammalian; Haloperidol; Hypothalamus; Kinetics; Norepinephrine; Nucleic Acid Hybridization; Pro-Opiomelanocortin; Rats; Rats, Inbred Strains; RNA Probes; RNA, Messenger | 1991 |
Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Topics: Adenylyl Cyclases; Animals; Benzazepines; Bromocriptine; Butaclamol; Corpus Striatum; Dopamine; Enzyme Activation; Ergolines; Guanine Nucleotides; Norepinephrine; Potassium; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sodium; Spiperone; Sulpiride | 1985 |
Hypothalamic D2 receptors mediate the preferential release of somatostatin-28 in response to dopaminergic stimulation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Butaclamol; Domperidone; Dopamine; Ergolines; Hypothalamus; Male; Metoclopramide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Somatostatin; Somatostatin-28 | 1986 |
Dopamine selectively inhibits angiotensin II-induced aldosterone secretion by interacting with D-2 receptors.
Topics: Adrenal Cortex; Aldosterone; Angiotensin II; Animals; Benzazepines; Bromocriptine; Butaclamol; Cyclic AMP; Dopamine; Haloperidol; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1988 |
Dopamine stimulated increase of GTP levels in the rat retina.
Topics: Animals; Apomorphine; Bromocriptine; Butaclamol; Dopamine; Dose-Response Relationship, Drug; Female; Guanosine Triphosphate; Isomerism; Isoproterenol; Rats; Rats, Inbred Strains; Retina | 1985 |
Dopaminergic stimulation of prolactin release.
Topics: Animals; Apomorphine; Bromocriptine; Butaclamol; Cells, Cultured; Dopamine; Haloperidol; Male; Pituitary Gland; Prolactin; Rats; Receptors, Dopamine | 1980 |
Decreased responsiveness of GH3 cells to the dopaminergic inhibition of prolactin.
Topics: Animals; Apomorphine; Bromocriptine; Butaclamol; Cell Line; Clone Cells; Dopamine; Dose-Response Relationship, Drug; Mice; Pituitary Neoplasms; Prolactin | 1980 |
Coat color in intact and neurointermediate lobe-grafted agouti mice: effect of dopamine agonists and antagonists.
Topics: Age Factors; Animals; Antipsychotic Agents; Apomorphine; Bromocriptine; Butaclamol; Dopamine Antagonists; Female; Hair Color; Male; Mice; Mice, Inbred C3H; Pimozide; Piribedil; Pituitary Gland; Receptors, Dopamine; Sulpiride | 1982 |
Mechanisms of inverse agonism of antipsychotic drugs at the D(2) dopamine receptor: use of a mutant D(2) dopamine receptor that adopts the activated conformation.
Topics: 1-Methyl-3-isobutylxanthine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Apomorphine; Binding, Competitive; Bromocriptine; Butaclamol; Chlorpromazine; CHO Cells; Clozapine; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; GTP-Binding Proteins; Haloperidol; Humans; Macromolecular Substances; Mutagenesis, Site-Directed; Phenethylamines; Piperidines; Protein Binding; Protein Conformation; Radioligand Assay; Receptors, Dopamine D2; Recombinant Fusion Proteins; Sodium; Spiperone; Structure-Activity Relationship; Sulpiride; Transfection; Tyramine | 2001 |